Bicara Therapeutics Inc. Common Stock (BCAX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bicara Therapeutics Inc. ...

    NASDAQ: BCAX · Real-Time Price · USD
    17.04
    0.33 (1.97%)
    At close: Oct 03, 2025, 3:59 PM
    16.92
    -0.70%
    After-hours: Oct 03, 2025, 05:42 PM EDT

    Bicara Therapeutics Common Stock Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Mar 31, 2023
    Cash & Equivalents
    		 436.61M 462.06M 489.71M 520.76M 203.85M 203.85M 230.44M n/a
    Short-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 6.84M 6.63M 65.82M 2.12M 2.09M 2.09M 2.09M -4.16M
    Receivables
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Current Assets
    		 7.79M 8.69M 12.82M 756K 2.22M n/a 633K n/a
    Total Current Assets
    		 444.39M 470.75M 502.53M 521.51M 206.08M 206.08M 231.07M 4.16M
    Property-Plant & Equipment
    		 2.35M 688K 845K 544K 619K 619K 815K n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 9.2M 7.32M 66.66M 2.66M 2.71M 2.71M 2.91M -4.16M
    Total Assets
    		 453.59M 478.08M 510M 524.17M 208.78M 208.78M 233.98M n/a
    Account Payables
    		 2.91M 2.74M 4.51M 1.96M 4.68M 4.68M 3.19M n/a
    Deferred Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Short-Term Debt
    		 1.07M 591K 607K 308K 300K n/a 285K n/a
    Other Current Liabilities
    		 11.08M 1.08M 2.48M 1.5M 817K n/a 1.46M n/a
    Total Current Liabilities
    		 17.23M 19.12M 17.99M 14.48M 16.07M 16.07M 15.09M n/a
    Long-Term Debt
    		 1.16M n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a 367.28M n/a 367.29M 17.28M
    Total Long-Term Liabilities
    		 1.16M n/a 131K 137K 367.49M 217K 367.67M 17.28M
    Total Liabilities
    		 18.39M 19.12M 18.12M 14.62M 383.56M 16.28M 382.75M 17.28M
    Total Debt
    		 2.24M 591K 738K 445K 517K 517K 657K n/a
    Book Value
    		 435.2M 458.96M 491.88M 509.56M -174.78M 192.5M -148.77M -17.28M
    Book Value Per Share
    		 7.98 8.43 9.04 9.37 -3.23 3.55 -2.8 -0.32
    Common Stock
    		 7K 7K 7K 7K 2K 2K 2K n/a
    Retained Earnings
    		 -285.25M -257.86M -221.02M -200.06M -182.58M -182.58M -153.02M n/a
    Comprehensive Income
    		 n/a n/a n/a n/a n/a n/a n/a -98.8M
    Shareholders Equity
    		 435.2M 458.96M 491.88M 509.56M -174.78M 192.5M -148.77M -17.28M
    Total Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist